Latest Articles
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer - Bioengineer.org
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer Bioengineer.org
Published: Sept. 20, 2026, 11:23 p.m.
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer - bioengineer.org
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer bioengineer.org
Published: Sept. 20, 2026, 11:23 p.m.
Cancer care is becoming personal: How biomarker testing is changing treatment decisions - theweek.in
Cancer care is becoming personal: How biomarker testing is changing treatment decisions theweek.in
Published: Aug. 28, 2026, 7:11 a.m.
Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer - CancerNetwork
Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer CancerNetwork
Published: Aug. 26, 2026, 8:08 p.m.
What Are Biomarkers And How Are They Transforming Women’s Health? - TechRound
What Are Biomarkers And How Are They Transforming Women’s Health? TechRound
Published: Aug. 24, 2026, 2:49 p.m.
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - AllSci
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer AllSci
Published: Aug. 18, 2026, 2:27 p.m.
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer - allsci.com
Faeth's PIKTOR combo gets FDA fast track for biomarker-selected endometrial cancer allsci.com
Published: Aug. 18, 2026, 2:27 p.m.
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer BioSpace
Published: Aug. 17, 2026, 1:47 p.m.
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Business Wire
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer Business Wire
Published: Aug. 17, 2026, 11:30 a.m.
New urinary biomarkers improve endometrial cancer detection - Bioengineer.org
New urinary biomarkers improve endometrial cancer detection Bioengineer.org
Published: Aug. 11, 2026, 7:44 p.m.
Link copied to clipboard!